A Review of Synthetic Access to Therapeutic Compounds Extracted from <i>Psilocybe</i>
Psychedelics are used for various pathologies of the central nervous system and are currently the subject of much research, some of which relates to the compounds contained in various <i>Psilocybe</i>-type hallucinogenic mushrooms. It is difficult, however, to obtain and purify sufficien...
Main Authors: | Raphaël Serreau, Ammar Amirouche, Amine Benyamina, Sabine Berteina-Raboin |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-12-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/16/1/40 |
Similar Items
-
Psilocybin for Treating Psychiatric Disorders: A Psychonaut Legend or a Promising Therapeutic Perspective?
by: Maurizio Coppola, et al.
Published: (2022-02-01) -
Extensive Collection of Psychotropic Mushrooms with Determination of Their Tryptamine Alkaloids
by: Klára Gotvaldová, et al.
Published: (2022-11-01) -
Production and extraction of psilocybin and psilocin from Psilocybe spp. mushrooms
by: Joana Margarida Costa Fernandes, et al.
Published: (2022-04-01) -
Therapeutic use of psilocybin: Practical considerations for dosing and administration
by: Caroline A. MacCallum, et al.
Published: (2022-12-01) -
Chemistry and Toxicology of Major Bioactive Substances in <i>Inocybe</i> Mushrooms
by: Jiri Patocka, et al.
Published: (2021-02-01)